Hanno P
Urol Clin North Am. 1986 Nov;13(4):577-90.
It is important that newly developed antibiotics be used so as to increase our ability to eradicate infection, rather than to complicate the treatment of infection by spawning the creation of organisms resistant to multiple antibiotics. One must peruse the literature with a very critical eye, as most new agents are touted as tremendous advances on past antibiotics. With rising medical costs becoming of ever-greater significance, proper choice of antimicrobial agent assumes more importance as well. The proper bacterial coverage in a given clinical setting, duration of treatment, and drug pharmacokinetics and the concept of the "total cost" of administering an antibiotic (taking into account fixed and variable hospital costs) all must be considered. Although it is virtually impossible to become experienced in using all of the currently available antibiotics, it is not necessary, either. Based on the literature and discussion with infectious disease colleagues, one can choose to use one or two antimicrobials in each broad class and gain the benefits of that class for his or her patients.
重要的是,使用新开发的抗生素是为了提高我们根除感染的能力,而不是通过催生对多种抗生素耐药的微生物来使感染治疗变得复杂。人们必须以非常批判性的眼光研读文献,因为大多数新药物都被吹捧为比过去的抗生素有巨大进步。随着医疗成本的不断上升变得越来越重要,正确选择抗菌药物也变得更加重要。在给定的临床环境中适当的细菌覆盖范围、治疗持续时间、药物药代动力学以及使用抗生素的“总成本”概念(考虑到固定和可变的医院成本)都必须加以考虑。虽然几乎不可能对目前所有可用的抗生素都有使用经验,但这也没有必要。根据文献以及与传染病领域同事的讨论,人们可以选择在每个大类中使用一两种抗菌药物,并为其患者获得该类药物的益处。